Questions or comments? Send us an email.
Leading a New Era of DiscoveryNew York, November 18—19, 2014Stern Auditorium, 1468 Madison Avenue

Trainee Entrepreneurship Forum and Networking Reception

This is the second year that we are offering a program developed exclusively for students and postdoctoral trainees associated with the Mount Sinai Health System during the SINAInnovations conference. The program includes a dynamic series of panels, workshops, and a large, popular networking reception. Attendance is free but space is limited and registration is required. We hope that you can join us!

Place: Hess Center for Science and Medicine, 1470 Madison Ave (101st and Madison), 2nd Floor
Date: Tuesday, November 18, 2014
Time: 2:00 PM to 6:00 PM
To Register: Please click here 

Trainee Entrepreneurship Forum

Panel: "How to Create Disruptive Technology in Science and Medicine"
Place: Davis Auditorium
Time: 2:00 PM to 2:45 PM

Workshops: Attend one of three concurrent workshops:

"Transforming Ideas into Technology" — Davis Auditorium
"How to Pitch Yourself and Your Idea" — Seminar Room A
"Funding Beyond the NIH Box" — Seminar Room B

Time: 2:45 PM to 3:30 PM

Lecture: "Career Opportunities and How to Network Your Way into One"
Place: Davis Auditorium
Time: 3:30 PM to 4:00 PM

Medical Student Session: "Personalizing Medical Education for the Future Physician-Innovator"
Place: Davis Auditorium
Time: 4:00 PM - 5:00 PM

Networking Reception

This networking event is designed for students and postdocs to learn about exciting career paths from industry experts. Professionals will be situated at tables where they will discuss their respective fields and what their jobs entail. Students and postdocs will be able to circulate between the tables to network and explore a variety of careers involving science, technology and medicine. Light refreshments will be served.
Sponsors: Graduate School of Biomedical Sciences, the Icahn School of Medicine at Mount Sinai, Office of Alumni and Development, Postdoc Executive Committee, and Women in Science
Place: Hess Center for Science and Medicine, 2nd Floor
Time: 4:00 PM to 6:00 PM

Organizing Committee: Nicole McKnight, PhD, Katharine Seip-Cammack, PhD, Susana Bardina, Brett Marinelli, and Howard Levin, MD

Questions? Please contact Katharine Seip-Cammack, PhD, at: katharine.seip-cammack@mssm.edu


Featured Speaker Bios
Piraye Yurttas Beim, PhDFounder and CEO, Celmatix
Piraye Yurttas Beim, PhD, is Founder and CEO of Celmatix, a New York City-based precision medicine company focused on female fertility that was recently named to Crain's "Top Biotech Companies to Watch."

Dr. Beim's embryology research at the University of Cambridge (UK) and doctoral work at Cornell (Weill) on the molecular genetics of mammalian infertility took a very personal turn when she began to notice many of the successful, career-minded women in her network begin to voice strong concerns about their biological clocks. That is when it dawned on her: What if women could understand their own fertility based on data and biology rather than age alone? How would that change how women made life-defining decisions? In that moment, Celmatix was born.

Dr. Beim has also been widely acknowledged as an emerging business leader. She was most recently recognized by Inc. magazine as one of the "10 Women to Watch in Tech," Crain's "40 Under 40," and named both a New York City Venture Fellow by the New York City Economic Development Corporation and a Life Sciences Fellow by the New York Biotechnology Association.
Ke Cheng, PhDFounder and CEO, HistoWiz
Ke Cheng, PhD, is a cancer researcher with expertise in mouse histopathology. She received her PhD in the laboratory of Pier Paolo Pandolfi at Harvard Medical School and led a team of investigators to publish papers in journals including Nature and Blood. Dr. Cheng was a Teaching Fellow at Harvard University, a NCCR Molecular Oncology postdoctoral fellow in the laboratory of Douglas Hanahan at ISREC, and a scientist at a cancer diagnostic company (NASDAQ:CGIX).

During her PhD and postdoctoral studies, Dr. Cheng realized that the current speed of histology and the method of collaboration greatly hinders cancer research progress. She founded HistoWiz to fight cancer cooperatively instead of individually by facilitating collaboration between scientists and pathologists. HistoWiz is a histology service company that processes tissue specimens and digitizes the results for biomedical researchers. It guarantees a three-day turnaround time from wet tissue submission to digital result delivery on a cloud database. It also provides online collaboration features; low-cost, long-term data management; and mouse cancer pathology expertise.

The novel HistoWiz Viewer allows instant global access to digital slides online on any PC, Mac or mobile devices without the need to download additional software or gigabyte-sized files. Dr. Cheng has been invited to give talks at events such as BioInnovation Day in Switzerland, Entrepreneurship Lab at Microsoft, Women in Entrepreneurship at NYU, MIT-CHIEF, and NY Innovation Showcase. Under her leadership, HistoWiz achieved breakeven status after its first month of operation at the Advanced Biotechnology Incubator in NYC and now has more than 200 customers around the world, from universities (such as MSKCC, Cornell, Harvard, MSSM, CINJ, NYU, SUNY Downstate), foundations (such as HHMI, Cancer Research UK, Orentriech), and biotechnology and pharmaceutical companies (such as Alexion, Rigel, Otsuka).
Mikail Kamal, BSFounder and CEO, Jibon Health Technologies
Mikail Kamal, a Bangladeshi-American who grew up in New York City, has a dual degree in Biomedical Engineering and Mathematics from Columbia University. He is currently pursuing his osteopathic medical degree at Touro College.

Following his strong belief that many public health issues in developing countries can be solved with low-cost solutions, Mr. Kamal founded Jibon Health Technologies in 2012 to address global health problems. Currently, Jibon Health Technologies, in collaboration with a partner organization in Bangladesh, is developing a low-cost and easy-to-use medical device to manage postpartum hemorrhage (PPH), excessive bleeding after child birth. PPH is the leading cause of maternal mortality worldwide, affecting 14 million women and claiming over 150,000 lives annually. Ninety-nine percent of these deaths occur in economically disadvantaged communities, largely due to a lack of available resources and training for midwives. Tampostat™ is a self-regulating, emergency obstetric device designed specifically for use in rural settings, by midwives and birth attendants with minimal medical training.

Among several recognitions, Mr. Kamal and Jibon Health Technologies have received the 2nd prize at 2013 Columbia University Business Plan Competition and the 2nd prize at 2013 NAPEC Innovation Conference. In August of 2014, he received the prestigious $250,000 Saving Lives at Birth Seed Grant, funded by Grand Challenges Canada, USAID, UKAID, The Bill and Melinda Gates Foundation and the Norwegian government to complete phase I and II clinical trials of Tampostat™ in Bangladesh.
Jason Mastaitis, PhDScientist, Regeneron Pharmaceuticals
Jason Mastaitis, PhD, was a graduate student at Mount Sinai from 2000-2008 in the laboratory of Dr. Charles Mobbs, where he studied hypothalamic glucose sensing. From there, he went on to Dr. Robert Sherwin's laboratory at Yale University for his postdoctoral fellowship to investigate hypothalamic mechanisms controlling counter-regulatory responses to hypoglycemia.

In 2011, he joined Regeneron Pharmaceuticals as a scientist in their Muscle and Metabolic Disease group. His focus is currently on discovering and developing therapeutics for obesity and Type II diabetes. He currently leads two antibody development programs and functions as in vivo lead on several others. Starting in the fall, he will also be working in collaboration with Columbia University on a human genetics initiative project to discover new and novel human mutations associated with susceptibility to diabetes and obesity.
Shane Mayack, PhDCo-founder, Executive Director, The Ligo Project
Shane Mayack, PhD, is a scientist interested in removing barriers that exist in the commercialization of scientific innovations, particularly those that could positively impact health. She worked as a Scientific Consultant/Project Manager at Cold Spring Harbor Labs (CSHL) and worked directly with Dr. Jim Watson on initiatives aimed at finding cancer treatments and cures. Much of this work focused on identifying barriers that exist in bringing scientific innovations in cancer treatment to the patient, identifying understudied areas of cancer biology, and coordinating think-tank style meetings at the Banbury Center of CSHL to address the issues.

During her academic training, her research focused on signaling molecules in immune cells that control immune cell fates, including inflammatory immune responses and autoimmunity, as well as studies on hematopoietic stem cell function. Dr. Mayack received her PhD from UMass Memorial Medical Center. She is also a founding member and scientific advisor at Gene-Home Inc.
Nicole McKnight, PhDCo-founder, KiiLN
Nicole McKnight, PhD, is a co-founder of KiiLN (Keystone for Incubating Innovation in Life sciences ? NYC), an incubator/accelerator for biotech start-ups in Harlem. KiiLN is a non-profit organization building affordable co-working laboratory space for growing drug discovery companies. Dr. McKnight is dedicated to promoting the growth of the biotech sector in New York City.

Dr. McKnight is a molecular and cell biologist whose twelve years of scientific research have made her well-versed in disease areas, such as cancer and neuroscience; she has also worked with animal models. She has trained at the Harvard Medical School, Cancer Research UK and most recently as a postdoctoral student at the Icahn School of Medicine at Mount Sinai. She found her love of start-ups while working for Gene Logic, Inc., now known as Ore Pharmaceuticals in Cambridge, Massachusetts.

Dr. McKnight received an AB (with honors) from the University of Chicago and a PhD from University College London.
Stephanie Mazlish, MBACo-founder and CEO, The Solution Lab
Stefanie Mazlish, MBA, is Co-founder and CEO of The Solution Lab, a nonprofit start-up which develops creative solutions for health care, pharmaceutical, and biotech companies facing strategic and operational challenges. The Solution Lab forms interdisciplinary teams of students and recent graduates with advanced degrees (PhD/MD/JD/MPH/MBA) to volunteer on management consulting projects in order to gain practical training as well as educational and networking opportunities. The Solution Lab also provides programming for educational workshops and initiatives, with a focus on creative thinking and entrepreneurship.

Ms. Mazlish has a professional background in payer side health care, allied health higher education, and management consulting. She was a semi-finalist in the NYU Stern Social Venture Competition twice, leading start-ups focusing on renewable energy and microfinance; she now judges for the International Impact Investing Challenge. Stefanie earned an MBA from NYU Stern School of Business with specialization in Strategy and Finance, and a BA from The University of Chicago.

View SINAInnovations in a larger map

Directions

SINAInnovations Event Address Recommended Parking
Icahn School of Medicine at
Mount Sinai Stern Auditorium
1468 Madison Avenue
(between 99th Sreet and 101st Street)
New York, NY 10029
CSM Underground Parking Garage
10 East 102nd Street
(between Madison Avenue and 5th Ave)
New York, NY 10029
Parking Garage Phone: 212-490-3460